![Alison Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Long
Directeur/Bestuurslid bij
TAYSHA GENE THERAPIES, INC.
Vermogen: 746 535 $ op 31-05-2026
Profiel
Alison Long is currently an Independent Director at Taysha Gene Therapies, Inc. since 2023 and Chief Medical Officer at Flightpath Biosciences, Inc. since 2023.
Former roles include Chief Medical Officer at Anokion SA from 2022 to 2023, Chief Medical Officer at Kaleido Biosciences, Inc. from 2021 to 2022, Chief Medical Officer & Senior Vice President at Freeline Therapeutics Holdings Ltd. in 2021, and Head-Clinical R&D at Spark Therapeutics, Inc. from 2019 to 2020.
Education includes a doctorate from George Mason University and an undergraduate degree from the University of the Witwatersrand.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 127.178 ( 0,05% ) | 746 535 $ | 31-05-2026 |
Actieve functies van Alison Long
| Bedrijven | Functie | Begin |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Directeur/Bestuurslid | 01-11-2023 |
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
Eerdere bekende functies van Alison Long
| Bedrijven | Functie | Einde |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| KALEIDO BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
| SPARK THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2020 |
Opleiding van Alison Long
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
